vancomycin has been researched along with Vascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abacigil, F; Durmaz, S; Erel, O; Ertugrul, B; Kozaci, LD; Kurtoglu, T; Ozturk, B | 1 |
| Bryan, M; Gerber, JS; Hamdy, RF; Hersh, AL; Hsu, AJ; Olson, JA; Stockmann, C; Tamma, PD | 1 |
| Duane, TM; Huang, DB; Puzniak, LA; Weigelt, JA | 1 |
1 review(s) available for vancomycin and Vascular Diseases
| Article | Year |
|---|---|
Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Female; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Vascular Diseases | 2012 |
2 other study(ies) available for vancomycin and Vascular Diseases
| Article | Year |
|---|---|
The effects of ozone on bacterial growth and thiol-disulphide homeostasis in vascular graft infection caused by MRSA in rats.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Cytokines; Disulfides; Homeostasis; Male; Methicillin-Resistant Staphylococcus aureus; Oxidants, Photochemical; Ozone; Random Allocation; Rats, Wistar; Reference Values; Reproducibility of Results; Serum Albumin; Staphylococcal Infections; Time Factors; Transplants; Treatment Outcome; Vancomycin; Vascular Diseases; Vascular Grafting | 2017 |
Epidemiology of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Child; Community-Acquired Infections; Female; Hospitalization; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Musculoskeletal Diseases; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Treatment Failure; Vancomycin; Vascular Diseases | 2017 |